Evidence map›Paper›PMID 35125835›Full record

ReviewThe Saudi dental journal2022

Antiviral effect of mouthwashes against SARS-COV-2: A systematic review.

Jhon Paul Iakov Mezarina Mendoza, Briggitte Patricia Trelles Ubillús, Gabriela Tazziana Salcedo Bolívar, Rosa Del Pilar Castañeda Palacios, Paulo Sergio Gilmar Herrera Lopez, David Alex Padilla Rodríguez, Karin Harumi Uchima Koecklin

Abstract readReview
In one paragraph

Review in The Saudi dental journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Ingredients in Commercially Available Mouthwashes.International dental journal · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Journal of oral microbiology · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jhon Paul Iakov Mezarina MendozaFaculty of Dentistry, National University of San Marcos, Lima, Perú.
Briggitte Patricia Trelles UbillúsFaculty of Dentistry, National University of San Marcos, Lima, Perú.
Gabriela Tazziana Salcedo BolívarFaculty of Dentistry, National University of San Marcos, Lima, Perú.
Rosa Del Pilar Castañeda PalaciosFaculty of Dentistry, National University of San Marcos, Lima, Perú.
Paulo Sergio Gilmar Herrera LopezFaculty of Dentistry, National University of San Marcos, Lima, Perú.
David Alex Padilla RodríguezFaculty of Dentistry, National University of San Marcos, Lima, Perú.
Karin Harumi Uchima KoecklinSchool of Dentistry, Universidad Científica del Sur, Lima, Perú.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis systematic review aimed to evaluate the antiviral effect of mouthwashes against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). MATERIAL AND

methodsAn electronic search was performed on PubMed, Scopus, Web of Science, Cochrane Library, LILACS, ProQuest, and Google Scholar, and was complemented by a manual search. Both clinical and

resultsA total of 907 records were found; after initial selection by title and abstract, 33 full-text articles were selected to be evaluated for eligibility. Finally, a total of 27 studies were included for the qualitative synthesis, including 16

conclusionAlthough povidone-iodine, cetylpyridinium chloride, and essential oils may be an alternative to reduce the viral load

Indexed as

APD, anionic phthalocyanine derivateCCID50, 50% of cell culture infectious doseCDCM, β-cyclodextrin-citroxCHX, chlorhexidine digluconateCoronavirusCOVID-19CPC, cetylpyridinium chlorideH2O2, hydrogen peroxideMouthwashesnon-RCT, non-randomized controlled trialsOCT, octenidine dihydrochlorideOral hygienePBS, phosphate-buffered salinepfu/mL, plaque forming units per milliliterPVP-I, povidone-iodineRCT, randomized controlled trialsRT-qPCR, quantitative reverse transcription polymerase chain reactionTCID50/mL, 50% of tissue culture infective doseViral load

Identifiers

PMID35125835
PMCPMC8806023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.